Skip to content
★ Sign in to follow
SR

Shivalik Rasayan Limited

Related company / holding
Medicamen Biotech Limited
Total declarations
7
Company
1
▲ Purchases (7 ops.)
€1.2M
▼ Sales (0 ops.)
—

Latest filing published 23 Mar 2024 for Medicamen Biotech Limited, €938k.

Filing timeline

BuySale
Shivalik Rasayan Limited

Insider track record

Disclosed buys
7
Disclosed sells
0
Signal history

Closed purchases

Market purchases
7

Not enough history yet: 0 closed purchases, at least 2 are needed.

Purchases by company

Shivalik Rasayan Limited: trading record in brief

Shivalik Rasayan Limited discloses dealings in Medicamen Biotech Limited to SEBI (PIT + SAST). In total, 7 filings cover trades dated from 7 December 2021 to 22 March 2024.

The open-market record is one-sided, with 7 purchases worth €1.2M and not one sale. Unlike grants, an open-market purchase is paid for by the insider, at the market price. So far in 2024, the count stands at 1 purchase and no sales.

The median purchase comes to €60k. None of the 6 purchases we analysed coincided with buying by another insider of the same company within 30 days.

The latest filing, published on 23 March 2024, reports an open-market purchase of €938k in Medicamen Biotech Limited. Between a trade and the moment it shows up on SEBI (PIT + SAST), the median delay is 2 days. Until a filing is published, the market cannot know about the trade. These figures are compiled from regulatory filings published by SEBI (PIT + SAST). They describe what insiders did and are not a recommendation.

Companies and markets linked to Shivalik Rasayan Limited

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations7 total
  • ▲
    Related company / holdingExecutivesMedicamen Biotech Limited
    85M INR10SEBI
    200,000 shares@ ₹424.355100.0% of flowEquity SharesSEBI:3686d1ca53547736e4b8f918aa9f47372a1105d4
    Canonical exit: 20 Jun 2024 (T+90)
  • ▲
    Related company / holdingExecutivesMedicamen Biotech Limited
    151,659 INR2SEBI
    200 shares@ ₹758.2951.0% of flowEquity SharesSEBI:93dd9972e5adb2e5221d65365331f0e9051de2cb
    Canonical exit: 20 Mar 2022 (T+90)
  • ▲
    Related company / holdingExecutivesMedicamen Biotech Limited
    77,690 INR2SEBI
    100 shares@ ₹776.900.5% of flowEquity SharesSEBI:327a6b71ce7e88ca16f431fcabcb3d450a80a0d5
    Canonical exit: 17 Mar 2022 (T+90)
  • ▲
    Related company / holdingExecutivesMedicamen Biotech Limited
    5M INR5SEBI
    7,084 shares@ ₹723.573532.9% of flowEquity SharesSEBI:3b38db47410af300cc3d21486165fca8721fc818
    Canonical exit: 14 Mar 2022 (T+90)
  • ▲
    Related company / holdingExecutivesMedicamen Biotech Limited
    8M INR0SEBI
    10,218 shares@ ₹757.170733.2% of flowEquity SharesSEBI:fdbb72e494cc5b6b7a32fad7801cc39b83adf282
    Canonical exit: 10 Mar 2022 (T+90)
  • ▲
    Related company / holdingExecutivesMedicamen Biotech Limited
    8M INR7SEBI
    10,218 shares@ ₹757.170749.7% of flowEquity SharesSEBI:e4c1d84ada3b09c037f559d192f81d42d801d02c
    Canonical exit: 10 Mar 2022 (T+90)
  • ▲
    Related company / holdingExecutivesMedicamen Biotech Limited
    2M INR4SEBI
    3,398 shares@ ₹725.414715.9% of flowEquity SharesSEBI:00126412c897188ac80d2d79590e63d1fbf67a5f
    Canonical exit: 7 Mar 2022 (T+90)

7 of 7 declarations